Cancer Research Funding

Curious how you can be a part of the 2018 election in DE? Join us for the Delaware Debates!

This summer and fall, Tennessee be participating in Cancer Votes, ACS CAN’s election program that educates the public and candidates about actions lawmakers should take to make fighting cancer a priority. We are focused on increasing cancer research funding, ensuring everyone has affordable, comprehensive health care coverage, and supporting efforts...

RSVP to join us at our annual Connecticut Volunteer Summit on Saturday, Oct. 20th. The training will be held at our Rocky Hill office from 9:00 AM to 2:00 PM. For more infomation contact [email protected]

Join other volunteers from across Oklahoma as we work to make cancer a priority! More details to follow. For questions, please contact Paula Warlick at: [email protected] or 918.477.5410

Please take time to register for this year's event which will include a panel disucussion about cancer rates and tobacco in Oklahoma.

Please join us for a discussion about how we can collaborate to overcome the barriers that impede progress and how we can improve our state's health.

Cancer research saves lives. It is the engine behind the ongoing progress in the fight against cancer, offering hope for better treatment, prevention and early detection, and improved quality of life. Yet, funding for cancer research has dropped over the last decade, when adjusting for inflation.

Cancer research saves lives. It is the engine behind the ongoing progress in the fight against cancer, offering hope for better treatment, prevention and early detection, and improved quality of life. Yet, funding for cancer research has dropped over the last decade, when adjusting for inflation.

Cancer research saves lives. It is the engine behind the ongoing progress in the fight against cancer, offering hope for better treatment, prevention and early detection, and improved quality of life. Yet, funding for cancer research has dropped over the last decade, when adjusting for inflation.

The 2018 event will discuss cancer research advancements, clinical trials— including barriers to clinical trials— along with the importance of public policy impact in the advancement of cancer research.